Medscape18d
Preoperative Administration of Epoetin alfa to Reduce Transfusion Requirements in Elderly Patients Having Primary Total Hip or Knee Reconstruction
We conducted a study comparing the safety and efficacy of preoperative recombinant human erythropoietin (epoetin alfa) in patients having major elective orthopaedic surgery and in matched ...
Hosted on MSN11mon
EC approves Bristol Myers Squibb’s Reblozyl for first-line MDS treatment
The trial assessed the efficacy and safety of Reblozyl compared to epoetin alfa, an erythropoiesis-stimulating agent, in treating anaemia due to MDS. It included subjects who needed red blood cell ...
Medscape14d
Cost-Minimization Analysis of Darbepoetin Alpha vs Epoetin Alpha
Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, retrospective review of the hospitalwide use of ...
pharmaphorum5d
BMS grabs key approval for Reblozyl in MDS
Reblozyl was found to be superior to standard ESA therapy with Amgen and Johnson & Johnson's Epogen/Procrit (epoetin alfa) at achieving those objectives, with almost 59% of patients on BMS' drug ...